If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email firstname.lastname@example.org .
Please tell us what format you need. It will help us if you say what assistive technology you use.
This letter from the DH Offender Health team and the National Research Committee announces the randomised trial of the heroin antidote naloxone in UK prisons.